Abstract
Therapeutic inertia is the failure of health-care providers to initiate or intensify therapy when therapeutic goals are not reached. Few studies have compared insulin initiation delay times with their expected negative effect on health outcomes. Our study quantifies the effects of delaying the start of insulin for patients with Type 2 Diabetes Mellitus (T2DM) on future A1c values, medical costs, and development of new T2D-related complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
